Almost a third of Australian medical oncologists and haematologists receive payments from the pharmaceutical industry, a rate three times higher than the average for specialist physicians, new research shows. The authors of the study say the findings are a reflection of the influence of industry in funding development of expensive novel cancer therapies rather than ...
Pharma payments to medical oncologists under the microscope
By Megan Howe
12 Aug 2020